NEW YORK (GenomeWeb News) – Mark Adams is now the scientific director at the J. Craig Venter Institute. He joins the institute from Case Western Reserve University, where he was an associate professor in the department of genetics. Previously, Adams worked at Celera, where he led the team that sequenced the first human genome, the fruit fly genome, and the mouse and rat genome, and he worked at the Institute for Genomic Research, serving as DNA sequencing facility director, assistant investigator, and director of the department of eukaryotic genomes.
Thermo Fisher Scientific has elected Lars Sorenson to serve on its corporate social responsibility board. Sorenson has been CEO and president of Novo Nordisk since 2000.
Roche Applied Science has appointed Thomas Shinecker to be the new president and lifecycle leader for sequencing at 454 Life Sciences. Shinecker, who will take the position in August, has spent over eight years at Roche.
Caprotec Bioanalytics has named Marc Voigt to be its managing director, chief financial officer, and chief operating officer. Voigt formerly was CFO and CBO at Medical Enzymes, and he held the same titles at Revotar Biopharmaceuticals.
Biocartis has appointed Hilde Windels to be CFO of the Biocartis Group. Windels has assumed the roles of managing director of Biocartis NV and director of Biocartis BV, subsidiaries in Switzerland and the Netherlands. She has taken over the CFO position from Christophe Bourilly, who will remain with the company as director of corporate development.
Lophius Biosciences has hired Karl Kleine to be the company's head of quality management and Kornelia Schlombs to serve as its scientific project manager for molecular biology. Kleine formerly was involved in quality management at Cogenics, and before that he worked at Epidauros Biotechnologie. Schlombs previously was in charge of genotyping studies at Epidauros.
Andrew Sharenberg has taken on the post of chief scientific officer at Cellectis Therapeutics. Sharenberg is a principal investigator and co-director of the Northwest Genome Engineering Consortium, a physician at Seattle Children's Hospital, and a professor at the University of Washington.
Bassem Bejjani has left Signature Genomics. With Lisa Shaffer, Bejjani co-founded Signature in 2003 and most recently served as the company's chief medical officer. Prior to his tenure at Signature, he was an associate director of the Kleberg Cytogenetics Laboratory at Baylor College of Medicine.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.